Not applicableUnknownNCT05492643
What this trial is testing
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
Who this might be right for
SARS-CoV-2SafetyImmunotoxicity
Zhongnan Hospital 1,000